Eric S. Furman

Eric S. Furman is a patent attorney at Knobbe, Martens, Olson & Bear, LLP, specializing in intellectual property protection for biotechnology, pharmaceuticals, and medical devices. His practice encompasses strategic patent counseling, procurement, patent landscape analyses, and advising on infringement and invalidity issues. He represents clients across a broad range of technologies, including genetically modified plants and organisms, stem cells, CAR T cells, oncology pharmaceuticals, vaccines, and various medical devices.

Furman's experience includes both offensive and defensive patent strategies. While his single tracked appearance in district court shows him representing a plaintiff, Dr. Falk Pharma GmbH, in the case against Ellodi Pharmaceuticals, L.P., his practice also features significant work challenging patents. He is active in inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB), having represented Dr. Falk Pharma GmbH as a petitioner in multiple IPRs against Ellodi Pharmaceuticals, L.P., challenging patents related to orally administered corticosteroid compositions.

Among his notable achievements, Furman successfully secured U.S. Patent No. 11,072,804 for client CombiGene AB, an accomplishment that contributed to a multi-million-dollar collaboration and licensing agreement for an epilepsy gene therapy.

Furman earned his J.D. from the University of Washington in 1998, a Ph.D. in Biochemistry from UCLA Medical School in 1995, and a B.S. in Biology, summa cum laude, from the University of New Mexico in 1988. He is admitted to the State Bar of California and registered to practice before the U.S. Patent and Trademark Office.